1. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
2. University of Salamanca, Salamanca, Spain;
3. Bristol-Myers Squibb, Redwood City, CA;
4. Bristol-Myers Squibb, Lawrenceville, NJ; and
5. University of Navarra, Pamplona, Spain